Drug Discovery Innovation Programme (DDIP) 2025

Services

Services

Inoviem provides a full range of services from drug discovery to clinical development by leveraging its platforms and direct access to human pathological specimens.
All the platforms and services are label-free with no modification of the original molecules.

Target & MoA Deconvolution

Unravel disease relevant Mode of Action (MoA) of your molecule directly on human tissues.

Target Validation & Engagement

Identify and validate targets in your study model or in Human.

Indication Prioritization

Thanks to our ex-vivo pharmacology expertise we identify the best disease and patients subgroups.

Patient Cohort Stratification

Using patients’ samples and PIMS® technology, we identify those individuals who can benefit best from your compound as soon as the early stage of preclinical studies.

Lead Compound Selection

Compounds of interest can be profiled for their drugability based on their mode of action and efficacy.

Biomarker Discovery

Translational pharmacology empowers your ability to identify biomarkers and advance clinical developments.

SPR and Proteomics

Advanced SPR and proteomics drive precise analysis of biomolecular interactions and protein landscapes.

Human Biological Samples Provision

Meticulous collection and biobanking of human samples fuel robust, translational research.
Platforms

Platforms

Inoviem provides breakthrough protein technologies for each phase of the drug development process.
One of the major advantages of our label-free technologies used under physiological conditions and in human tissue – NPOT® and PIMS® – is that the test compound retains its original structure, as well as the exact same molecular structure that would be used in therapy

NPOT®

Unlocking drug mechanism of action in native biological contexts

Read more

LIPS

Designed to measure drug-target interactions with high accuracy in native environments, including cultured cells and patient tissues.

Read more

PIMS®

Designed to study molecular interactions and predict therapeutic responses in biomedical research

Read more

Biomarkers discovery

Methodology for the proteomic profiling of human individuals in the context of translational evaluation of biomarkers and clinical development of new drug candidates.

Read more
Knowledge centre
About us
About us
Inoviem Scientific is a Bioanalytical R&D company established in 2011 in Strasburg – France.

Our mission

Our mission is clear: to get the right treatment to the right patients within the right therapeutic window.

Read more

Our team

Management team

Scientific board

Supervisory board & investors

Read more
Contact us

Our team will be present at Drug Discovery Innovation Programme (DDIP) 2025

– Drug Discovery Innovation Programme (DDIP) 2025 | 25-26 September 2025, Barcelona (Spain)

Is your drug discovery program generating the data that truly matters for clinical success and investor confidence? 🤔

Inoviem is excited to announce that we will be attending the Drug Discovery Innovation Programme (DDIP) Europe, taking place from September 25th to 26th, 2025, at the InterContinental in Barcelona, Spain.

This premier event is a key opportunity for leaders at the forefront of pharmaceutical R&D and biotech innovation to connect and shape the future of medicine.

Our External R&D Innovation Manager, Alessandro Bona, will be representing Inoviem and is looking forward to reconnecting with existing partners and meeting new innovators. He will be available for one-on-one meetings to discuss potential collaborations and explore how we can help advance your most promising drug discovery projects.

If you would like to arrange a meeting with Alessandro during the conference, please contact us at a.bona@inoviem.com.

We look forward to seeing you in Barcelona!

Privacy Overview

This website uses cookies to improve your experience while you navigate through the website. Out of these, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may affect your browsing experience.

Necessary

Always Enabled

Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously.

Cookie	Duration	Description
cookielawinfo-checkbox-advertisement	1 year	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Advertisement".
cookielawinfo-checkbox-analytics	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics".
cookielawinfo-checkbox-functional	11 months	The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional".
cookielawinfo-checkbox-necessary	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary".
cookielawinfo-checkbox-others	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other.
cookielawinfo-checkbox-performance	11 months	This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance".
elementor	never	This cookie is used by the website's WordPress theme. It allows the website owner to implement or change the website's content in real-time.
viewed_cookie_policy	11 months	The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data.

Functional

Performance

Analytics

Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc.

Cookie	Duration	Description
_ga	2 years	This cookie is installed by Google Analytics. The cookie is used to calculate visitor, session, campaign data and keep track of site usage for the site's analytics report. The cookies store information anonymously and assign a randomly generated number to identify unique visitors.
_ga_61RXK9ZCWR	2 years	This cookie is installed by Google Analytics.

Others

Our team will be present at Drug Discovery Innovation Programme (DDIP) 2025

– Drug Discovery Innovation Programme (DDIP) 2025 | 25-26 September 2025, Barcelona (Spain)

Is your drug discovery program generating the data that truly matters for clinical success and investor confidence? 🤔

Inoviem is excited to announce that we will be attending the Drug Discovery Innovation Programme (DDIP) Europe, taking place from September 25th to 26th, 2025, at the InterContinental in Barcelona, Spain.

This premier event is a key opportunity for leaders at the forefront of pharmaceutical R&D and biotech innovation to connect and shape the future of medicine.

If you would like to arrange a meeting with Alessandro during the conference, please contact us at a.bona@inoviem.com.

We look forward to seeing you in Barcelona!

SERVICES

KNOWLEDGE CENTER

PLATFORMS

ABOUT US

PRIVACY POLICY